JOSEPH SHANKLIN: Open Payments
NPI 1356453021 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,827 in 56 payments from 14 companies in 2025. Trend: 2023 $1,576 · 2024 $1,220 · 2025 $1,827
Food & beverage: $1,577Consulting: $150Education: $100
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $345 |
| Neurocrine BioSciences, Inc. | 6 | $262 |
| JAZZ PHARMACEUTICALS INC. | 3 | $218 |
| Vanda Pharmaceuticals Inc. | 7 | $168 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $168 |
| Otsuka America Pharmaceutical, Inc. | 6 | $158 |
| HARMONY BIOSCIENCES LLC | 3 | $148 |
| E.R. Squibb & Sons, L.L.C. | 5 | $110 |
| TMS NeuroHealth Centers Inc. | 4 | $73 |
| Janssen Pharmaceuticals, Inc | 2 | $54 |
Products named: Auvelity, INGREZZA, XYWAV, CAPLYTA, REXULTI, HETLIOZ, COBENFY, TMS NeuroHealth Centers Inc..
Industry payments across FL — which companies pay providers there.
